MMM
56
2
MRK
63
3
PNW
53
-3
NOV
52
4
LRCX
62
6
LUV
68
2
EQIX
64
5
ZTS
21
2
EFX
54
2
C
82
3
FIS
58
2
NSC
48
-11
MAT
50
-5
HBAN
82
3
DTE
38
-4
BK
74
5
NFLX
40
3
PRU
62
2
SPG
48
2
STI
18
11
MMM
56
2
MRK
63
3
PNW
53
-3
NOV
52
4
LRCX
62
6
LUV
68
2
EQIX
64
5
ZTS
21
2
EFX
54
2
C
82
3
FIS
58
2
NSC
48
-11
MAT
50
-5
HBAN
82
3
DTE
38
-4
BK
74
5
NFLX
40
3
PRU
62
2
SPG
48
2
STI
18
11
Financhill
Back

Coca-Cola FEMSA SAB de CV Vs. CRISPR Therapeutics AG Industry Stock Comparison

Buy
57

KOF
Coca-Cola FEMSA SAB de CV

Last Price:
$95.05
Seasonality Move:
3.06%
Sell
43

CRSP
CRISPR Therapeutics AG

Last Price:
$55.85
Seasonality Move:
14.46%
Buy
57
Coca-Cola FEMSA SAB de CV (KOF) is a Buy

Is Coca-Cola FEMSA SAB de CV a Buy, Sell or Hold?

  • The current Coca-Cola FEMSA SAB de CV [KOF] share price is $94.96. The Score for KOF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • KOF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $55.86. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KOF Stock Price Chart

What is Coca-Cola FEMSA SAB de CV's stock price today?

  • The Coca-Cola FEMSA SAB de CV share price today is $94.96
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KOF is experiencing slight buying pressure.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $55.86
    The current trend is relatively stagnant and CRSP is experiencing slight buying pressure.

KOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.61 Buy
Relative Strength Index (14 RSI): 67.53 Buy
Chaikin Money Flow: 172912 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.49 - 92.51) Buy
Bollinger Bands (100): (83.03 - 89.31) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 49.16 Sell
Chaikin Money Flow: 78181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.94 - 57.06) Buy
Bollinger Bands (100): (52.44 - 65.4) Sell

KOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.93 Buy
20-day SMA: 90.59 Buy
50-day SMA: 88.06 Buy
200-day SMA: 89.46 Buy
8-day EMA: 92.77 Buy
20-day EMA: 91.19 Buy
50-day EMA: 88.99 Buy
200-day EMA: 87.84 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.25 Sell
20-day SMA: 55.05 Buy
50-day SMA: 58.96 Sell
200-day SMA: 51.1 Buy
8-day EMA: 55.79 Buy
20-day EMA: 55.79 Buy
50-day EMA: 56.36 Sell
200-day EMA: 37.56 Buy

Coca-Cola FEMSA SAB de CV Earnings Growth & KOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.92 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

Coca-Cola FEMSA SAB de CV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):